Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2276
PUT
GameStop
GME
$12.5B
| $4.06M | ﹤0.01% |
166,400
-183,600
| -52% | -$4.92M |
2025 Q1
1 quarter
|
|
2277
Genpact
G
$5.59B
| $4.05M | ﹤0.01% |
92,086
-72,666
| -44% | -$3.29M |
2013 Q4
46 quarters
|
|
|
HTO
2278
H2O America
HTO
$2.52B
| $4.05M | ﹤0.01% |
77,903
+26,018
| +50% | +$1.38M |
2019 Q1
25 quarters
|
|
2279
MannKind Corp
MNKD
$1.22B
| $4.04M | ﹤0.01% |
1,081,245
+633,348
| +141% | +$2.79M |
2019 Q1
25 quarters
|
|
2280
Alkami Technology
ALKT
$1.49B
| $4.04M | ﹤0.01% |
134,114
+47,414
| +55% | +$1.32M |
2022 Q1
13 quarters
|
|
2281
Allegro MicroSystems
ALGM
$7.37B
| $4.03M | ﹤0.01% |
117,759
-6,417
| -5% | -$160K |
2022 Q1
13 quarters
|
|
2282
Harmony Biosciences
HRMY
$2.31B
| $4.02M | ﹤0.01% |
127,113
+43,823
| +53% | +$1.41M |
2022 Q1
13 quarters
|
|
2283
DXC Technology
DXC
$1.77B
| $4M | ﹤0.01% |
261,432
+111,977
| +75% | +$1.72M |
2017 Q2
32 quarters
|
|
|
SAIL
2284
SailPoint Inc
SAIL
$11.7B
| $4M | ﹤0.01% |
174,819
+1,300
| +0.7% | +$24.5K |
2025 Q1
1 quarter
|
|
2285
Arlo Technologies
ARLO
$1.38B
| $3.99M | ﹤0.01% |
235,295
+79,089
| +51% | +$1.01M |
2018 Q3
27 quarters
|
|
2286
CAVA Group
CAVA
$6.36B
| $3.99M | ﹤0.01% |
47,317
+427
| +0.9% | +$36.4K |
2023 Q2
8 quarters
|
|
2287
CALL
DraftKings
DKNG
$9.23B
| $3.98M | ﹤0.01% |
+92,900
| New | +$3.33M |
2025 Q2
0 quarters
|
|
2288
ADT
ADT
$4.57B
| $3.98M | ﹤0.01% |
470,251
-66,928
| -12% | -$548K |
2018 Q1
29 quarters
|
|
2289
Kodiak Gas Services
KGS
$5.49B
| $3.98M | ﹤0.01% |
116,218
+46,118
| +66% | +$1.6M |
2023 Q3
7 quarters
|
|
2290
CALL
Merck
MRK
$356B
| $3.98M | ﹤0.01% |
50,300
-199,700
| -80% | -$15.9M |
2023 Q4
6 quarters
|
|
2291
Gates Industrial Corp
GTES
$7B
| $3.98M | ﹤0.01% |
172,869
-193,395
| -53% | -$3.9M |
2018 Q1
29 quarters
|
|
2292
Standard BioTools
LAB
$292M
| $3.97M | ﹤0.01% |
3,306,375
+205,836
| +7% | +$228K |
2023 Q3
7 quarters
|
|
|
LADR
2293
Ladder Capital
LADR
$1.09B
| $3.95M | ﹤0.01% |
367,496
+12,674
| +4% | +$133K |
2014 Q1
45 quarters
|
|
2294
Kennametal
KMT
$2.49B
| $3.95M | ﹤0.01% |
171,899
+41,079
| +31% | +$855K |
2013 Q2
48 quarters
|
|
2295
City Holding Co
CHCO
$2.01B
| $3.94M | ﹤0.01% |
32,191
+10,030
| +45% | +$1.18M |
2016 Q2
36 quarters
|
|
2296
John Wiley & Sons Class A
WLY
$2.41B
| $3.93M | ﹤0.01% |
88,163
+26,519
| +43% | +$1.12M |
2013 Q2
48 quarters
|
|
2297
RLI Corp
RLI
$5.13B
| $3.93M | ﹤0.01% |
54,481
+9,510
| +21% | +$713K |
2013 Q2
48 quarters
|
|
2298
Fulgent Genetics
FLGT
$591M
| $3.93M | ﹤0.01% |
197,579
+5,581
| +3% | +$109K |
2020 Q2
20 quarters
|
|
2299
Sabre
SABR
$795M
| $3.93M | ﹤0.01% |
1,242,401
+74,716
| +6% | +$192K |
2014 Q2
44 quarters
|
|
2300
ePlus
PLUS
$2.44B
| $3.92M | ﹤0.01% |
54,424
+13,559
| +33% | +$892K |
2013 Q2
48 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.